Immune Response News and Research

RSS

Researchers harness immune system to reveal new clues to produce HIV vaccine

The immune system is the body's best defense in fighting diseases like HIV and cancer. Now, an international team of researchers is harnessing the immune system to reveal new clues that may help in efforts to produce an HIV vaccine.

4 Feb 2019

Study: IL10 receptor critical to prevent uncontrolled infection and gut damage

A new study has identified the master regulator that maintains a healthy gut and limits damage by parasitic whipworms.

1 Feb 2019

Study may lead to a greater understanding of the mechanisms behind neuropathic pain

In animal models of a totally crushed peripheral nerve, the damaged axons are broken down, allowing healthy ones to regrow.

1 Feb 2019

Scientists explore new treatment targets for retinal damage

Scientists at the Medical College of Georgia at Augusta University are looking at new treatment targets for the retinal damage that often accompanies diseases like diabetes, glaucoma and hypertension.

31 Jan 2019

USC researchers use AI to identify blood-based markers of Alzheimer's disease

Nearly 50 million people worldwide have Alzheimer's disease or another form of dementia. While age is the greatest risk factor for developing the disease, researchers believe most Alzheimer's cases occur as a result of complex interactions among genes and other factors. But those factors and the role they play are not known--yet.

29 Jan 2019

Cells in the intestines play key role in inducing acute inflammatory episodes

Medical researchers discover a type of cell which induces acute inflammatory episodes in bowel diseases.

29 Jan 2019

New study elucidates role of signaling molecule in development of myocarditis

Researchers of Ludwig-Maximilians-Universitaet in Munich have shown that a protein called midkine, a member of the class of signaling molecules known as cytokines, is a key driver of inflammation in the heart muscle that can lead to heart failure in patients with myocarditis.

29 Jan 2019

Stand Up To Cancer creates Dream Team focused on finding therapies for T-cell lymphoma

Stand Up To Cancer announced here today the creation of an $8 million Dream Team of top scientists focused on finding therapies for T-cell lymphoma, a rare cancer of the blood and immune system, using chimeric antigen receptors (CARs) to trigger the immune system to attack and destroy cancerous cells.

29 Jan 2019

New precision medicine treatment for bone cancer in dogs opens door for human clinical trials

In a first-of-its-kind study, scientists at the University of Missouri have helped advance a patient-specific, precision medicine treatment for bone cancer in dogs.

29 Jan 2019

NIH grants awarded to Nanoscope to recruit talent and develop optogenetic delivery platforms

Retinal dystrophies such as Age-related macular degeneration (AMD) are a major cause of vision loss in aging populations. National Eye Institute (NEI) estimates that the prevalence of advanced AMD will grow to nearly 3 million by 2020.

29 Jan 2019

NIAID-funded clinical trial of Ebola vaccines is underway at Cincinnati Children's

A Phase 1 clinical trial of investigational vaccines intended to protect against Zaire ebolavirus (Ebola) is underway at Cincinnati Children's Hospital Medical Center in the United States. The study is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

28 Jan 2019

Mechanism of inflammation initiation through NLRP3 inflammasome activation revealed

Inflammation is the response of our immune system to infection and harmful environmental effects. On one hand, it is beneficial as it defends our body against microbes. On the other hand, excessive inflammation leads to serious diseases.

28 Jan 2019

Injection of genetically modified virus effectively treats metastatic melanoma patients

Injection of a genetically modified virus that induces the body's own immune cells to attack metastatic melanoma effectively treated almost 40 percent of patients with tumors that could not be surgically removed, according to researchers from three prominent cancer centers in a study published as an "article in press" on the Journal of the American College of Surgeons website in advance of print publication.

28 Jan 2019

Immune Response News and Research

Researchers harness immune system to reveal new clues to produce HIV vaccine

Study: IL10 receptor critical to prevent uncontrolled infection and gut damage

Study may lead to a greater understanding of the mechanisms behind neuropathic pain

Scientists explore new treatment targets for retinal damage

USC researchers use AI to identify blood-based markers of Alzheimer's disease

Cells in the intestines play key role in inducing acute inflammatory episodes

New study elucidates role of signaling molecule in development of myocarditis

Stand Up To Cancer creates Dream Team focused on finding therapies for T-cell lymphoma

New precision medicine treatment for bone cancer in dogs opens door for human clinical trials

NIH grants awarded to Nanoscope to recruit talent and develop optogenetic delivery platforms

NIAID-funded clinical trial of Ebola vaccines is underway at Cincinnati Children's

Mechanism of inflammation initiation through NLRP3 inflammasome activation revealed

Injection of genetically modified virus effectively treats metastatic melanoma patients

Study suggests link between keloids and high risk of breast cancer among African Americans

LJI awarded $22 million contract renewal to host and expand Immune Epitope Database

Researchers design interleukin protein to balance overshooting immune response

Clinical testing begins for temperature-stable experimental tuberculosis vaccine

Cancer Research UK announces £60 million funding to tackle global cancer challenges

Top institutions in the U.S. win Cancer Research UK's Grand Challenge competition

Ludwig researchers find ways to make resistant melanomas susceptible to immunotherapy

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News